Animal insulin-like growth factor binding proteins and their biological functions

Veterinarni Medicina

Volumn 47, Issue 2-3, 2002, Pages 75-84

  Kostecká, Zuzana ^a   Blahovec, J ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

Author keywords

Insulin like growth factor; Insulin like growth factor binding protein

Indexed keywords

FULVESTRANT; GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6;

ANIMAL TISSUE; BINDING AFFINITY; BODY FLUID; CANCER; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CELL SURFACE; CULTURE MEDIUM; DIFFERENTIAL DIAGNOSIS; ENDOCRINE DISEASE; GLYCOSYLATION; HALF LIFE TIME; HUMAN; HUMAN TISSUE; NONHUMAN; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW;

ANIMALIA;

EID: 0036479284     PISSN: 03758427     EISSN: None     Source Type: Journal    
DOI: 10.17221/5807-VETMED     Document Type: Review

References (77)

1. Andress D.L., Birnbaum R.S. (1992): Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem., 267, 22467-22472
2. Bach L.A. (1999): Insulin-like growth factor binding protein-6: the "forgotten" binding protein? Horm. Metab. Res., 31, 226-234
3. Bach L.A., Thotakura N.R., Rechler M.M. (1992): Human insulin-like growth factor binding protein-6 is O-glycosy-lated. Biochem. Biophys. Res. Commun., 186, 301-307
4. Bar R.S., Clemmons D.R., Boes M., Busby W.H., Booth B.A., Dake B.L., Sandra A. (1990): Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology, 127, 1078-1086
5. Baumrucker C.R., Erondu N.E. (2000): Insulin-like growth factor system in the bovine mammary gland and milk. J. Mammary Gland Biol. Neoplasia, 5, 53-64
6. Blahovec J., Kostecká Z., Mester J., Cavaille F. (1997): Peptidic components of sheep amniotic fluid regulate cell proliferation of BP-A31 cells. Vet. Med.-Czech, 42, 185-189
7. Blahovec J., Kostecká Z., Mester J., Cavaille F. (1999): Peptide substances of ovine and caprine amniotic fluid with cell proliferating activity. Folia Vet., 43, 37-39
8. Blahovec J., Kostecká Z., Cavaille F., Lacroix M.G., Mester J. (2001a): Insulin-like growth factor binding proteins and mitogenic activity of partially fractionated sheep amniotic fluid. Acta Vet. Hung., 49, 65-70
9. Blahovec J., Kostecká Z., Lacroix M.C., Cabanie L., Godeau F., Mester J., Cavaille F. (2001b): Mitogenic activity of high molecular weight forms of IGF-II in amniotic fluid. J. Endocrinol., 169, 563-572
10. Blum W.F., Jenne E.W., Reppin F., Kietzmann K., Ranke M.B., Bierich J.R. (1991): Insulin-like growth factor-I (IGF-I)-binding protein complex is better mitogen than free IGF-I. Endocrinology, 125, 766-772
11. Boomsma R.A., Mavrogianis P.A., Fazleabas A.T., Jaffe R.C., Verhage H.G. (1994): Detection of IGFBP-1 in cat implantation sites. Biol. Reprod., 51, 392-399
12. Burch W.M., Correa J., Shively J.E., Powell D.R. (1990): The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro. J. Clin. Endocrinol. Metab., 70, 173-180
13. Butler J.H., Gluckman P.D. (1986): Circulating insulin-like growth factor-binding proteins in fetal, neonatal and adult sheep. J. Endocrin., 109, 333-338
14. Butt A.J., Williams A.C. (2001): IGFBP-3 and apoptosis, a license to kill? Apoptosis, 6, 199-205
15. Camacho-Hubner C., Busby Jr W.H., McCusker R.H., Wright G., Clemmons D.R. (1992): Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J. Biol. Chem., 267, 11949-11956
16. Campbell P.G., Novak J.F. (1991): Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells. J. Cell. Physiol., 149, 293-300
17. Carr J.M., Grant P.A., Francis G.L., Owens J.A., Wallace J.C., Alton P.E. (1994): Isolation and characterization of ovine IGFBP-4: protein purification and cDNA sequence. J. Mol. Endocrinol., 13, 219-236
18. Clemmons D.R., Gardner L.I. (1990): A factor contained in plasma is required for binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. J. Cell. Physiol., 145, 129-135
19. Cohen P., Rosenfeld R.G. (1994): Physiologic and clinical relevance of the insulin-like growth factor binding proteins. Curr. Opin. Pediatr., 6, 462-467
20. Delos Rios P., Hill D.J. (1999): Cellular localization and expression of insulin-like growth factors (IGFs) and IGF binding proteins within the epiphyseal growth plate of the ovine fetus: possible functional implications. Can. J. Physiol. Pharmacol., 77, 235-249
21. De Mellow J.S.M., Baxter R.C. (1998): Growth hormone, dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun., 156, 199-204
22. D'Ercole A.J., Drop S.L.S., Kortleve D.J. (1985): Somatomedin-C/insulin, like growth factor I-binding proteins in human amniotic fluid and in fetal and postnatal blood: Evidence of immunological homology. J. Clin. Endocrinol. Metab., 61, 612-617
23. Erickson G.F., Mei Li D., Ling N., Shimasaki S. (1996): Growth factor regulation of IGFBP-4 in rat granulosa cells. Front. Endocrinol., 19, 145-151
24. Erickson G.F., Kubo T., Li D., Kim H., Shimasaki S. (1998): The IGF system in the ovary. In: Takano K., Hizuka N., Takahashi S.I. (eds.): Molecular Mechanisms to Regulate the Activities of Insulin-like Growth Factors. Elsevier Science B.V. 185-193
25. Falconer J., Davies J.J., Zhang H.P., Smith R. (1991): Release of insulin-like growth factor I by the sheep placenta in vitro. Reprod. Fertil. Dev., 3, 379-384
26. Ferry Jr R.J., Cerri R.W., Cohen P. (1999): IGFBPs: new proteins, new functions. Horm. Res., 51, 53-67
27. Feyen J.H.M., Evans D.B., Binkert CH., Heinrich G.F., Geisse S., Kocher H.P. (1991): Recombinant human [Cys281] insulin-like growth factor-binding protein-2 inhibits both basal and insulin-like growth factor-I-stimulated proliferation and collagen synthesis in fetal rat calvariae. J. Biol. Chem., 266, 19469-19474
28. Frauman A.G., Tsuzaki S., Moses A.C. (1989): The binding characteristics and biological effects in FRTL5 cells of placental protein-12, an insulin-like growth factor-binding protein purified from human amniotic fluid. Endocri-nology, 124, 2289-2296
29. Giannella-Neto D., Kamyar A., Sharifi B., Pirola C.J., Kupfer J., Rosenfeld R.G., Forrester J.S., Fagin J.A. (1992): Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein-4. Circ. Res., 71, 646-656
30. Gourmelen M., Perin L., Le Bouc Y. (1994): IGFs and their binding proteins. Nucl. Med. Biol., 21, 297-302
31. Grimberg A., Cohen P. (2000): Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell Physiol., 183, 1-9
32. Hardouin S., Gourmelen M., Noguiez P., Seurin D., Roghani M., Le Bouc Y., Povoa G., Merimee T.J., Hossenlopp P., Binoux M. (1989): Molecular forms of serum insulin-like growth factor (IGF) binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J. Clin. Endocrinol. Metab., 69, 1291-1301
33. Hodgkinson S.C., Moore L., Napier J.R., Davis S.R., Bass J.J., Gluckman P.D. (1989): Characterization of insulin-like growth factor binding proteins in ovine tissue fluids. J. Endocrinol., 120, 429-438
34. Hoeflich A., Fettscher O., Lahm H., Blum W.F., Kolb H.J., Engelhardt D., Wolf E., Weber M.M. (2000): Overexpression of insulin-like growth factor binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res., 15, 834-838
35. Hossner K.L., McCusker R.H., Dodson M.V. (1997): Insulin-like growth factors and their binding proteins in domestic animals. Anim. Sci., 64, 1-15
36. Huynh H., Yang X., Pollak M. (1996): Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding 3 autocrine loop in human breast cancer cells. J. Biol. Chem., 271, 1016-1021
37. Jones I.J., D'Ercole A.J., Camacho-Hubner C., Clemmons J.R. (1991): Phosphorylation of IGFBP-1 in cell culture and in vivo, Effects of affinity for IGF-I. Proc. Natl. Acad. Sci. USA, 88, 7481-7485
38. Jones J.I., Clemmons D.R. (1995): Insulin-like growth factors and their binding proteins: biological actions. Endocrin. Rev., 16, 3-34
39. Jones J.I., Gockerman A., Busby Jr W.H., Wright G., Clemmons D.R. (1993): Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alfa5beta1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA, 90, 10553-10557
40. Kim H.S., Nagalla S.R., Oh Y., Wilson E., Roberts C.T., Rosenfeld R.G. (1997): Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Natl. Acad. Sci. USA, 94, 12981-12986
41. Koistinen R., Kalkkinen N., Huhtala M.-L., Seppala M., Bohn H., Rutanen E.-M. (1986): Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology, 118, 1375-1378
42. Koistinen R., Itkonen O., Selenius P., Seppala M. (1990): Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem. Biophys. Res. Commun., 173, 408-415
43. Koistinen R., Angervo M., Leinonen P., Hakala T., Seppala M. (1993): Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin. Chim. Acta, 215, 189-199
44. Kopple J.D. (1992): The rationale for the use of growth hormone or IGF-I in adult patients with renal failure. Miner. Electrolyte Metab., 18, 269-275
45. Kostecká Z., Blahovec J. (1999): Insulin-like growth factor binding proteins and their functions (minireview). Endocrin. Regulat., 33, 90-94
46. Lee C.Y., Chung C.S., Simmen F.A. (1993): Ontogeny of the porcine insulin-like growth factor system. Mol. Cell. Endocrinol., 93, 71-80
47. Lewitt M.S., Cameron-Smith D., Clarke N.M., Saunders H., Phuyal J.L. (1998): Factors regulating the rat insulin-like growth factor binding protein-1 response to octreotide. J. Endocrinol., 158, 61-68
48. Liu L., Delbe J., Blat Z., Zapf J., Harel L. (1992): Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and II. J. Cell. Physiol., 153, 15-21
49. Martin J.L., Baxter R.C. (1992): Insulin-like growth factor binding protein-3: Biochemistry and Physiology. Growth Regulation, 2, 88-99
50. McCusker R.H., Clemmons D.R. (1992): The insulin-like growth factor binding proteins: Structure and biological functions. In: Schofield P.N. (ed.): The Insulin-like Growth Factors. Structure and Biological Functions. Oxford University Press, Oxford, New York, Tokyo. 110-149
51. McGuire Jr.W.L., Jackson J.G., Figueroa J.A., Shimasaki S., Powell D.R., Yee D. (1992): Regulation of insulin-like growth factor binding protein (IGFBP) expression by breast cancer cells: Use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J. Nat. Cancer Inst., 84, 1336-1341
52. McLellan K.C., Hooper S.B., Bocking A.D., Delhanty P.J.D., Phillips I.D., Hill D.J., Han V.K.M. (1992): Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus. Endocrinology, 131, 1619-1628
53. Mondschein J.S., Smith S.A., Hammond J.M. (1990): Production of insulin-like growth factor binding proteins (IGFBPs) by porcine granulosa cells: Identification of IGFBP-2 and-3 and regulation by hormones and growth factors. Endocrinology, 127, 2298-2306
54. Moser D.R., Lowe Jr.W.L., Dake B.L., Booth B.A., Boes M., Clemmons D.R., Bar R.S. (1992): Endothelial cells express insulin-like growth factor-binding proteins 2 to 6. Mol. Endocrinol., 6, 1805-1814
55. Nonoshita L.D., Wathen N.C., Dsupin B.A., Chard T., Giudice L.C. (1994): Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions. J. Clin. Endocrinol. Metab., 79, 1249-1255
56. Oh Z. (1997): IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth. Endocrine, 7, 111-113
57. Oh J. (1998): IGF-independent regulation of breast cancer growth by IGFBPs. Breast Cancer Res. Treat., 47, 283-293
58. Ross M., Francis G.L., Szabo L., Wallace J.C., Ballard F.J. (1989): Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-II but not des-(1-3)-IGF-I. Biochem. J., 258, 267-272
59. Russell W.E., Van Wyk J.J. (1989): Peptide growth factors. In: De Groot L.J. (ed.): Endocrinology. W. B. Saunders Company. 2504-2524
60. Russell W.E., Van Wyk J.J. (1995): Peptide growth factors. In: De Groot L.J. (ed.): Endocrinology. W. B. Saunders Company. 2590-2623
61. San Roman G.A., Magoffin D.A. (1992): Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. J. Clin. Endocrinol. Metab., 75, 1010-1016
62. Schoen T.J., Beebe D.C., Clemmons D.R., Chader G.J., Waldbillig R.J. (1992): Local synthesis and developmental regulation of avian vitreal insulin-like growth factor-binding proteins: A model for independent regulation in extravascular and vascular compartments. Endocrinology, 131, 2846-2854
63. Seppala M., Koistinen R., Rutanen E.-M. (1994): Uterine endocrinology and paracrinology: insulin-like growth factor binding protein-1 and placental protein 14 revisited. Hum. Reprod., 9, 917-925
64. Shimasaki S., Murakami K., Morita Y., Erickson G.F. (1996): Regulation of IGFBP-4 proteolysis by FSH in rat granulosa cells. Front. Endocrin., 19, 133-143
65. Underwood L.E. (1994): Insulin-like growth factor-I in growth hormone-resistant short stature. In: Bondy C.A. (ed.): Clinical uses of IGF-I. Ann. Intern. Med., 120, 593-601
66. Van Buul-Offers S.C., Van Kleffens M., Koster J.G., Lindenbergh-Kortleve D.J., Gresnigt M.G., Drop S.L., Hoogerbrugge C.M., Bloemen R.J., Koedam J.A., Van Neck J.W. (2000): Human IGFBP-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice. Endocrinology, 141, 1493-1499
67. Wallen L.D., Myint W., Nygard K., Shimasaki S., Clemmons D.R., Han V.K.M. (1997): Cellular distribution of insulin-like growth factor binding protein mRNAs and peptides during rat lung development. J. Endocrinol., 155, 313-327
68. Wang J.F., Fraher L.J., Hill D.J. (1990): Characterization of insulin-like growth factor-binding protein in ovine amniotic fluid. J. Endocrinol., 127, 325-333
69. Werther G.A., Russo V., Baker N., Butler G. (1998): The role of the insulin-like growth factor system in the developing brain. Horm. Res., 49, 37-40
70. Westwood M., Gibson J.M., Davies A.J., Young R.J., White A. (1994): The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J. Clin. Endocrinol. Metab., 79, 1735-1741
71. Wetterau L.A., Moore M.G., Lee K.W., Shim M.L., Cohen P. (1999): Novel aspects of the insulin-like growth factor binding proteins. Mol. Genet. Metab., 68, 161-181
72. Yallampalli C., Rajaraman S., Nagamani M. (1993): Insulin-like growth factor binding proteins in the rat uterus and their regulation by oestradiol and growth hormone. J. Reprod. Fertil., 97, 1501-1505
73. Yamanaka Y., Wilson E.M., Rosenfeld R.G., Oh Y. (1997): Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J. Biol. Chem., 272, 30729-30734
74. Yang Y.W.-H., Pioli P., Fiorelli G., Brandi M.L., Rechler M.M. (1993): Cyclic adenosine monophosphate stimulates insulin-like growth factor binding protein-4 and its messenger ribonucleic acid in a clonal endothelial cell line. Endocrinology, 133, 343-351
75. Zapf J. (1995): Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol., 132, 645-654
76. Zapf J. (1997): Total and free IGF serum levels. Eur. J. Endocrinol., 136, 146-147
77. Zumkeller W., Schofield P.N. (1992): The role of isulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch. B Cell Pathol., 62, 207-220